The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid


Journal

Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785

Informations de publication

Date de publication:
07 2021
Historique:
revised: 22 02 2021
received: 01 08 2020
accepted: 24 02 2021
pubmed: 12 3 2021
medline: 11 3 2022
entrez: 11 3 2021
Statut: ppublish

Résumé

Microglia are the innate immune cells of the central nervous system that adopt rapid functional changes in response to Damage Associated Molecular Patterns, including aggregated β-Amyloid (Aβ) found in Alzheimer's disease (AD). microRNAs (miRNAs) are post-transcriptional modulators that influence the timing and magnitude of microglia inflammatory responses by downregulating the expression of inflammatory effectors. Recent studies implicate miR-155, a miRNA known to regulate inflammatory responses, in the pathogenesis of neurodegenerative disorders including multiple sclerosis, ALS, familial Parkinson's disease, and AD. In this work, we asked if miR-155 expression in microglia modifies cellular behaviors in response to fibrillar Aβ

Identifiants

pubmed: 33694209
doi: 10.1002/glia.23988
pmc: PMC9098129
mid: NIHMS1799132
doi:

Substances chimiques

Amyloid beta-Peptides 0
Lipopolysaccharides 0
MIRN155 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1736-1748

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM095421
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG051437
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG052354
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS073848
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Front Cell Neurosci. 2015 Feb 23;9:54
pubmed: 25755635
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9184-9
pubmed: 21576471
J Investig Med. 2010 Dec;58(8):961-7
pubmed: 21030878
Brain Pathol. 2018 Nov;28(6):791-805
pubmed: 29222823
Ann Neurol. 2015 Jan;77(1):75-99
pubmed: 25381879
J Cereb Blood Flow Metab. 2019 Oct;39(10):1919-1935
pubmed: 30628839
Annu Rev Immunol. 2017 Apr 26;35:441-468
pubmed: 28226226
J Neurochem. 2016 Jan;136 Suppl 1:49-62
pubmed: 25708596
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9
pubmed: 17242365
Neuroscience. 2015 Nov 19;309:84-99
pubmed: 25772789
J Neurochem. 2013 Dec;127(5):592-9
pubmed: 23952003
PLoS One. 2012;7(10):e46082
pubmed: 23091595
Immunity. 2014 Oct 16;41(4):605-19
pubmed: 25367574
Brain Behav Immun. 2009 Mar;23(3):309-17
pubmed: 18814846
Folia Neuropathol. 2019;57(3):211-219
pubmed: 31588707
Neurotherapeutics. 2019 Jan;16(1):216-230
pubmed: 30225790
Mol Neurobiol. 2016 Dec;53(10):6709-6715
pubmed: 26659872
PLoS One. 2016 Jan 29;11(1):e0147721
pubmed: 26824354
Immunity. 2002 Nov;17(5):583-91
pubmed: 12433365
Brain Behav Immun. 2016 Feb;52:1-8
pubmed: 26148445
Int J Biochem Mol Biol. 2012;3(1):105-16
pubmed: 22509485
J Exp Med. 2014 Jul 28;211(8):1533-49
pubmed: 25002752
Neurobiol Aging. 2003 Oct;24(6):807-15
pubmed: 12927763
J Immunol. 2014 Jan 1;192(1):358-66
pubmed: 24319262
Mol Cell Proteomics. 2013 Oct;12(10):2833-44
pubmed: 23816988
J Neurosci. 2008 Dec 24;28(52):14156-64
pubmed: 19109498
Int J Alzheimers Dis. 2012;2012:737846
pubmed: 22655214
Stroke. 2012 Nov;43(11):3063-70
pubmed: 22933588
Gene. 2013 Dec 10;532(1):1-12
pubmed: 23246696
J Neurosci. 2015 Jul 1;35(26):9764-81
pubmed: 26134658
Glia. 2013 Jan;61(1):91-103
pubmed: 22653784
Cell. 2012 Mar 16;148(6):1172-87
pubmed: 22424228
Neurobiol Aging. 2014 Feb;35(2):345-56
pubmed: 24064186
J Neurosci. 1998 Mar 15;18(6):2161-73
pubmed: 9482801
J Alzheimers Dis. 2014;39(2):253-9
pubmed: 24157723
Cell Mol Neurobiol. 2018 Jul;38(5):1021-1031
pubmed: 29302837
Cold Spring Harb Perspect Med. 2018 Feb 1;8(2):
pubmed: 29419406
Glia. 2012 May;60(5):717-27
pubmed: 22290798
J Exp Med. 2011 Jun 6;208(6):1189-201
pubmed: 21555486
Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S69-75
pubmed: 9562472
Nat Rev Immunol. 2010 Feb;10(2):111-22
pubmed: 20098459
Annu Rev Immunol. 2012;30:295-312
pubmed: 22224773
J Nat Sci. 2017 Sep;3(9):
pubmed: 28959732
Mol Neurobiol. 2009 Oct;40(2):139-56
pubmed: 19629762
Neuron. 1996 Sep;17(3):553-65
pubmed: 8816718
Hum Mol Genet. 2014 Dec 1;23(23):6286-301
pubmed: 24990149
Nat Rev Neurosci. 2018 Oct;19(10):622-635
pubmed: 30206328
Neuron. 2013 Sep 4;79(5):873-86
pubmed: 24012002

Auteurs

Macarena S Aloi (MS)

Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.

Katherine E Prater (KE)

Department of Neurology, School of Medicine, University of Washington, Seattle, Washington, USA.

Bryce Sopher (B)

Department of Neurology, School of Medicine, University of Washington, Seattle, Washington, USA.

Stephanie Davidson (S)

Department of Neurology, School of Medicine, University of Washington, Seattle, Washington, USA.

Suman Jayadev (S)

Department of Neurology, School of Medicine, University of Washington, Seattle, Washington, USA.

Gwenn A Garden (GA)

Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
Department of Neurology, School of Medicine, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH